Bharat Biotech's Covaxin shows 77.8 % efficacy in phase 3 data trial: Sources
The review meeting took place taking before Bharat Biotech`s pre-submission meeting on Wednesday with the World Health Organization (WHO), for the approval for their COVID vaccine `Covaxin`.
Jun 22, 2021, 15:52 PM IST